BlackRock’s PharMerica Corporation PMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-3,987,716
| Closed | -$117M | – | 5064 |
|
|
2017
Q3 | $117M | Buy |
3,987,716
+71,352
| +2% | +$2M | 0.01% | 1751 |
|
|
2017
Q2 | $103M | Sell |
3,916,364
-59,187
| -1% | -$1.45M | 0.01% | 1778 |
|
|
2017
Q1 | $93M | Buy |
3,975,551
+3,967,862
| +51,604% | +$97.9M | 0.01% | 1822 |
|
|
2016
Q4 | $193K | Sell |
7,689
-892
| -10% | -$22.5K | ﹤0.01% | 2168 |
|
|
2016
Q3 | $242K | Sell |
8,581
-13
| -0.2% | -$333 | ﹤0.01% | 2054 |
|
|
2016
Q2 | $212K | Buy |
8,594
+6,425
| +296% | +$159K | ﹤0.01% | 2071 |
|
|
2016
Q1 | $48K | Buy |
2,169
+132
| +6% | +$3.51K | ﹤0.01% | 2384 |
|
|
2015
Q4 | $71K | Buy |
2,037
+1,456
| +251% | +$45.6K | ﹤0.01% | 1890 |
|
|
2015
Q3 | $17K | Sell |
581
-190
| -25% | -$6.38K | ﹤0.01% | 2492 |
|
|
2015
Q2 | $26K | Hold |
771
| – | – | ﹤0.01% | 2285 |
|
|
2015
Q1 | $22K | Hold |
771
| – | – | ﹤0.01% | 2332 |
|
|
2014
Q4 | $16K | Hold |
771
| – | – | ﹤0.01% | 2493 |
|
|
2014
Q3 | $19K | Hold |
771
| – | – | ﹤0.01% | 2377 |
|
|
2014
Q2 | $22K | Sell |
771
-366
| -32% | -$10.2K | ﹤0.01% | 2344 |
|
|
2014
Q1 | $32K | Hold |
1,137
| – | – | ﹤0.01% | 2136 |
|
|
2013
Q4 | $25K | Sell |
1,137
-114
| -9% | -$2.07K | ﹤0.01% | 2265 |
|
|
2013
Q3 | $17K | Buy |
1,251
+178
| +17% | +$2.4K | ﹤0.01% | 2366 |
|
|
2013
Q2 | $15K | Buy |
+1,073
| New | +$15.2K | ﹤0.01% | 2455 |
|
BlackRock's PMC Position: Q4 2017 in Review
BlackRock sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 3,987,716 shares — an estimated $117M sold.
BlackRock first reported a position in PMC in Q2 2013 and held it in 18 quarters. The position peaked at $117M in Q3 2017. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.
- BlackRock reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
- BlackRock sold 3,987,716 PharMerica Corporation shares in Q4 2017, an estimated $117M.
- BlackRock first reported a position in PharMerica Corporation in Q2 2013 and held it in 18 quarters.
- BlackRock's PharMerica Corporation position peaked at $117M in Q3 2017.
- 0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.
Based on BlackRock's 13F filing for Q4 2017, filed 9 Feb 2018.